Increased neural response to trauma scripts in posttraumatic stress disorder following paroxetine treatment: A pilot study.
Neuroimaging studies of individuals with posttraumatic stress disorder (PTSD) have revealed altered patterns of activity in medial prefrontal brain regions, including the anterior cingulate cortex (ACC), an area implicated in affect regulation. Selective serotonin reuptake inhibitors (SSRIs) have been shown to effectively treat PTSD symptoms, but there remains a lack of functional neuroimaging research examining the effects of psychopharmacological treatment on brain function in PTSD. The purpose of this pilot study was to assess the effects of the SSRI paroxetine on neural responses to traumatic memories in a small sample of patients with PTSD, as measured with PET imaging; we hypothesized that paroxetine treatment would be associated with increased regional cerebral blood flow (rCBF) in the medial prefrontal cortex. Thirteen participants with PTSD were given controlled-release paroxetine (paroxetine CR) or placebo in a randomized, double-blind fashion for 12 weeks. Participants underwent brain imaging using positron emission tomography (PET) before and at the end of treatment in conjunction with exposure to neutral scripts and personalized trauma scripts. Participants treated with paroxetine CR and placebo both exhibited significantly increased rCBF in the ACC during trauma versus neutral script presentations; however, we noted an increase in function in the orbitofrontal cortex (OFC) in paroxetine-treated (but not placebo-treated) participants. Participants in both groups showed decreases in overall PTSD symptomatology following treatment; paroxetine-treated participants showed a slightly greater percentage decrease in symptoms. These preliminary findings indicate that increased ACC function represents a nonspecific response to treatment, whereas increased OFC function is specifically associated with paroxetine treatment in PTSD. These pilot data reveal putative mechanisms for SSRI treatment in PTSD and substantiate the need for large-scale placebo-controlled studies investigating these effects.
Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30306, United States. nfani1@student.gsu.edu
Negar
N
Fani
Ali
A
Ashraf
Nadeem
N
Afzal
Farhan
F
Jawed
Noriyuki
N
Kitayama
Lai
L
Reed
J Douglas
JD
Bremner
D000328:Adult; D002540:Cerebral Cortex / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D017374:Paroxetine / Q000627:therapeutic use*; D010865:Pilot Projects; D049268:Positron-Emission Tomography; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013313:Stress Disorders, Post-Traumatic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors
J Clin Psychiatry. 2001 Nov;62(11):860-8
11775045
Arch Gen Psychiatry. 1997 Apr;54(4):364-74
9107153
Biol Psychiatry. 2003 Feb 1;53(3):204-10
12559652
Am J Psychiatry. 1999 Apr;156(4):575-84
10200737
Arch Gen Psychiatry. 2004 Feb;61(2):168-76
14757593
Am J Psychiatry. 2001 Dec;158(12):1982-8
11729013
Acta Psychiatr Scand. 2010 Jan;121(1):41-51
19522883
JAMA. 2003 Jun 18;289(23):3125-34
12813118
Ann N Y Acad Sci. 2006 Jul;1071:87-109
16891565
Biol Psychiatry. 2005 Apr 15;57(8):832-40
15820703
Biol Psychiatry. 2004 Apr 1;55(7):759-65
15039006
J Affect Disord. 2004 May;80(1):45-53
15094257
Biol Psychiatry. 1999 Apr 1;45(7):806-16
10202567
PLoS Med. 2008 Feb;5(2):e45
18303940
Am J Psychiatry. 1999 Nov;156(11):1787-95
10553744
Arch Gen Psychiatry. 1996 May;53(5):380-7
8624181
Am J Psychiatry. 2001 Nov;158(11):1920-2
11691703
Biol Psychiatry. 2003 May 15;53(10):879-89
12742675
Dialogues Clin Neurosci. 2006;8(4):445-61
17290802
Neurosci Lett. 2001 Jan 12;297(2):101-4
11121880
Biol Psychiatry. 2004 Dec 1;56(11):853-61
15576062
BMC Psychiatry. 2004 Oct 14;4:30
15482603
Nature. 2002 Nov 7;420(6911):70-4
12422216
Ann N Y Acad Sci. 2006 Jul;1071:67-79
16891563
Clin Psychol Rev. 2006 Jan;26(1):32-49
16242823
J Trauma Stress. 1995 Jan;8(1):75-90
7712061